GO:0110154 | RNA decapping | 50.0% (1/2) | 10.24 | 0.000829 | 0.015535 |
GO:0044093 | positive regulation of molecular function | 50.0% (1/2) | 8.8 | 0.002235 | 0.018627 |
GO:0043085 | positive regulation of catalytic activity | 50.0% (1/2) | 8.91 | 0.002082 | 0.019522 |
GO:0110156 | methylguanosine-cap decapping | 50.0% (1/2) | 10.31 | 0.000789 | 0.019716 |
GO:0035770 | ribonucleoprotein granule | 50.0% (1/2) | 8.94 | 0.002032 | 0.021777 |
GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA | 50.0% (1/2) | 10.75 | 0.000582 | 0.021838 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 50.0% (1/2) | 8.41 | 0.002937 | 0.022025 |
GO:0065009 | regulation of molecular function | 50.0% (1/2) | 7.79 | 0.004498 | 0.024096 |
GO:0140677 | molecular function activator activity | 50.0% (1/2) | 7.56 | 0.005298 | 0.024835 |
GO:0006402 | mRNA catabolic process | 50.0% (1/2) | 8.1 | 0.003648 | 0.024871 |
GO:0008047 | enzyme activator activity | 50.0% (1/2) | 7.65 | 0.004983 | 0.024914 |
GO:0006401 | RNA catabolic process | 50.0% (1/2) | 7.85 | 0.004319 | 0.024915 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 50.0% (1/2) | 8.96 | 0.002003 | 0.025032 |
GO:0000932 | P-body | 50.0% (1/2) | 9.13 | 0.001786 | 0.026796 |
GO:0050790 | regulation of catalytic activity | 50.0% (1/2) | 7.86 | 0.004312 | 0.02695 |
GO:0009892 | negative regulation of metabolic process | 50.0% (1/2) | 6.36 | 0.012151 | 0.028478 |
GO:0098772 | molecular function regulator activity | 50.0% (1/2) | 6.31 | 0.012581 | 0.028592 |
GO:0031324 | negative regulation of cellular metabolic process | 50.0% (1/2) | 6.37 | 0.012084 | 0.029237 |
GO:0010605 | negative regulation of macromolecule metabolic process | 50.0% (1/2) | 6.39 | 0.011893 | 0.029732 |
GO:0099080 | supramolecular complex | 50.0% (1/2) | 7.21 | 0.006758 | 0.029815 |
GO:0030234 | enzyme regulator activity | 50.0% (1/2) | 6.4 | 0.011803 | 0.030526 |
GO:0016071 | mRNA metabolic process | 50.0% (1/2) | 6.44 | 0.011512 | 0.030836 |
GO:0003729 | mRNA binding | 50.0% (1/2) | 6.47 | 0.011227 | 0.031187 |
GO:0046700 | heterocycle catabolic process | 50.0% (1/2) | 6.83 | 0.00877 | 0.031323 |
GO:0044270 | cellular nitrogen compound catabolic process | 50.0% (1/2) | 6.83 | 0.00877 | 0.031323 |
GO:0009890 | negative regulation of biosynthetic process | 50.0% (1/2) | 6.52 | 0.010903 | 0.031451 |
GO:0010629 | negative regulation of gene expression | 50.0% (1/2) | 6.93 | 0.0082 | 0.03237 |
GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA | 50.0% (1/2) | 11.17 | 0.000433 | 0.032446 |
GO:0031327 | negative regulation of cellular biosynthetic process | 50.0% (1/2) | 6.52 | 0.010857 | 0.032571 |
GO:1901361 | organic cyclic compound catabolic process | 50.0% (1/2) | 6.63 | 0.010039 | 0.032736 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 50.0% (1/2) | 6.56 | 0.010552 | 0.032976 |
GO:0034655 | nucleobase-containing compound catabolic process | 50.0% (1/2) | 6.95 | 0.008045 | 0.033519 |
GO:0019439 | aromatic compound catabolic process | 50.0% (1/2) | 6.66 | 0.009867 | 0.033637 |
GO:0048519 | negative regulation of biological process | 50.0% (1/2) | 5.96 | 0.015994 | 0.034273 |
GO:0048523 | negative regulation of cellular process | 50.0% (1/2) | 5.99 | 0.015713 | 0.034662 |
GO:0009057 | macromolecule catabolic process | 50.0% (1/2) | 5.79 | 0.017997 | 0.037494 |
GO:0044248 | cellular catabolic process | 50.0% (1/2) | 5.61 | 0.020327 | 0.041204 |
GO:0043228 | non-membrane-bounded organelle | 50.0% (1/2) | 5.32 | 0.024835 | 0.04776 |
GO:0043232 | intracellular non-membrane-bounded organelle | 50.0% (1/2) | 5.32 | 0.024832 | 0.04901 |